載入...

Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance

Although high rates of complete hematologic and cytogenetic remission have been observed in patients with chronic phase chronic myeloid leukemia (CML) treated with imatinib, a short duration of response with eventual emergence of imatinib resistance has also been reported in a subset of CML patients...

全面介紹

Na minha lista:
書目詳細資料
Main Authors: Martinelli, Giovanni, Iacobucci, Ilaria, Soverini, Simona, Palandri, Francesca, Castagnetti, Fausto, Rosti, Gianantonio, Baccarani, Michele
格式: Artigo
語言:Inglês
出版: Dove Medical Press 2007
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC2721303/
https://ncbi.nlm.nih.gov/pubmed/19707322
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!